in a double-blind multiclinic trial , a new nonsteroidal anti-inflammatory agent ( ibuprofen ) was compared with an established therapeutic agent ( phenylbutazone-alka ) for the treatment of osteoarthritis .
C0020740
ibuprofen
C0029408
osteoarthritis